NIBEC Co., Ltd. (KOSDAQ:138610)

Market Cap	439.32B
Revenue (ttm)	33.58B
Net Income (ttm)	-2.46B
Shares Out	11.31M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	244,411
Average Volume	615,395
Open	42,350
Previous Close	41,700
Day's Range	39,700 - 42,900
52-Week Range	12,800 - 48,200
Beta	0.89
RSI	55.44
Earnings Date	Aug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-eup, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 96
• Stock Exchange: KOSDAQ
• Ticker Symbol: 138610

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.